Has Corey Hartman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $743,956 in general payments to Corey Hartman, MD across 1,343 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Corey Hartman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Corey Hartman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Corey Hartman, MD

Dermatology · Birmingham, ALNPI 1124078902

Payments from drug & device makers

$743,956in general payments, 2019–2025

Across 1,343 payments — averaging $553.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$516K
Galderma Laboratories, L.p.$122K
Sun Pharmaceutical Industries Inc.$33K
Mayne Pharma Commercial LLC$22K
Sanofi US Services Inc.$18K
Almirall LLC$11K
plus $22K from 41 others

What the payments were for

Consulting fees$218,19038%
Speaking & faculty fees$285,89050%
Travel & lodging$35,5006%
Food & beverage$27,7445%
Education$5,3231%
Entertainment$320%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	552	$516,189
Galderma Laboratories, L.p.	127	$121,580
Sun Pharmaceutical Industries Inc.	64	$33,079
Mayne Pharma Commercial LLC	62	$22,479
Sanofi US Services Inc.	17	$17,791
Almirall LLC	25	$10,822
Ortho Dermatologics, A Division Of Bausch Health US, LLC	63	$3,799
E.r. Squibb & Sons, L.L.C.	24	$2,895
VYNE Pharmaceuticals Inc.	12	$1,985
Merz North America, Inc.	17	$1,977
Janssen Scientific Affairs, LLC	1	$1,750
Novartis	71	$1,481
Incyte Corporation	20	$695
LEO Pharma Inc.	42	$683
Biofrontera Inc.	13	$627
Sanofi	13	$621
Arcutis Biotherapeutics, Inc.	32	$585
Promius Pharma LLC	1	$500
Globus Medical	7	$460
Johnson & Johnson	22	$451
Regeneron Healthcare Solutions, Inc.	21	$430
Revance Therapeutics, Inc.	7	$411
Pfizer	23	$358
Lilly USA, LLC	16	$297
Dermira, Inc.	8	$291
Amgen	15	$269
Alphatec Spine, Inc	3	$255
EPI Health, LLC	12	$222
Encore Dermatology Inc.	8	$182
Dermavant Sciences, Inc.	4	$106
Eli Lilly	1	$99
Aclaris Therapeutics, Inc.	6	$91
Strata Skin Sciences, Inc.	6	$84
Boehringer Ingelheim	3	$57
Medimetriks Pharmaceuticals, Inc.	3	$52
Mylan Pharmaceuticals Inc.	3	$42
Botanix SB Inc	2	$41
Nabriva Therapeutics, PLC	3	$38
UCB, Inc.	2	$33
Organon	4	$28
Mission Pharmacal Company	2	$26
Journey Medical Corporation	1	$21
DUSA Pharmaceuticals, Inc.	1	$20
Verrica Pharmaceuticals Inc.	1	$19
Sandoz	1	$17
Merck	1	$11
Prugen, Inc. Pharmaceuticals	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BOTOX$116,185
Winlevi$31,799
BOTOX COSMETIC$25,899
FABIOR$21,651
NATRELLE SALINE-FILLED BREAST IMPLANTS$18,625
Seysara$10,436
KYBELLA$9,271
SORILUX$7,276
DORYX$6,250
ABSORICA LD$6,122
Humira$4,500
Rinvoq$3,707
Skyrizi$3,600
REVOLVE$3,145
ALTRENO$3,004
AMZEEQ$1,750
ZILXI$1,750
Tremfya$1,750
XEOMIN$914
Sernivo$500

How this compares

$743,956 in reported general payments places this provider in the 95th percentile of 168 dermatology providers in Alabama.

See all dermatology providers in Alabama →

Medicare billing

Part B allowed, 2024

$59,997

Medicare patients

108

Services billed

3,047

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab	19	$208,162
Dupixent PenDupilumab	20	$110,258
Clobetasol Propionate	38	$1,166
Fluocinonide	18	$733
Minoxidil	48	$671
Finasteride	57	$621
Mupirocin	68	$567
Doxepin Hcl	13	$554
Fluconazole	27	$455
ValacyclovirValacyclovir Hcl	12	$445
Spironolactone	14	$443
MethotrexateMethotrexate Sodium	25	$423
Betamethasone Dipropionate	12	$366
Ketoconazole	17	$280
Clindamycin Phosphate	12	$278

Paid to pharmacies, not to this prescriber.

Other dermatology in Birmingham

Boni ElewskiBirmingham$5.5M
James KrellBirmingham$4M
Tiffany MayoBirmingham$1.4M
Melanie AppellBirmingham$983K
Julie HarperBirmingham$920K
Lauren GrahamBirmingham$582K
Kristy CurlBirmingham$158K
Rajini MurthyBirmingham$153K
Sarah Lauren HugheyBirmingham$144K
Megan CherryBirmingham$137K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →